In this episode of Intel on AI guest Aviv Regev, Executive Vice President of Genentech Research and Early Development, talks with host Abigail Hing Wen, Intel AI Tech Evangelist and New York Times best-selling author, about biomedicine and artificial intelligence (AI).

The two discuss Aviv’s work on circuitry in cells, the future of experimental biology, why increasing the diversity of data is key to creating algorithms that can find patterns in genomic variants, and how strengthening global networks will help society better prepare for the next pandemic. Hear more from Aviv in a special episode of Genentech’s science podcast “Studying the Symphony of Cells.”

Follow Genentech on Twitter: twitter.com/genentech
Follow Abigail on Twitter: twitter.com/abigailhingwen
Learn more about Intel’s work in AI: intel.com/ai

Tags: Abigail Hing Wen, AI, artificial intelligence, Aviv Regev, Biomedicine, deep learning, Genentech, machine learning, natural language processing, Supercomputing
 
Posted in: Artificial Intelligence, Audio Podcast, Healthcare, Intel, Intel on AI